Loading...
Androgen receptor abnormalities in castration-recurrent prostate cancer
The androgen receptor (AR) plays a critical role in prostate cancer (PCa) development and progression. Despite the success of androgen-deprivation therapy, remission occurs in almost all cases. This stage of the disease is called castration-recurrent PCa (CRPC). CRPC cells adapt to low circulating l...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835169/ https://ncbi.nlm.nih.gov/pubmed/20228873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eem.09.34 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|